Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
Angela L. Liang,
Payam Katebi Kashi,
Mark Hopkins,
Anna Beavis,
Stephanie Gaillard,
Ie-Ming Shih,
Amanda N. Fader
Affiliations
Angela L. Liang
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Payam Katebi Kashi
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Mark Hopkins
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Anna Beavis
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Stephanie Gaillard
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Ie-Ming Shih
Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States
Amanda N. Fader
The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, United States; Corresponding author at: 600 N Wolfe St, Phipps Bldg, Rm 287, Baltimore, MD 21287, United States.
